RETRACTED: Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor-in-Chief and the authors. Panels from Figure 2A appear similar to panels from Figure 3A of the article published by Xiangyang Dou, Meihua Wang, Tao Zhang and Jiapei Yao in The Anatomical Record (2019) https://doi.org/10.1002/ar.24324, Figures 2B and 6B of the article published by C.-L. Xue, H.-G. Liu, B.-Y. Li, S.-H. He and Q.-F. Yue in the Eur. Rev. Med. Pharmacol. Sci. 23 (2019) 5101-5112 https://doi.org/10.26355/eurrev_201906_18174 and Figure 3B of the article published by Bo Liu and Shuo Yu in Biomedicine & Pharmacotherapy 107 (2018) 243-253 https://doi.org/10.1016/j.biopha.2018.07.177. Panels from Figure 6D appear similar to panels from Figure 8D of the article published by The Anatomical Record (2019) https://doi.org/10.1002/ar.24324, Figure 7E of the article published by Ying Niu, Jinping Zhang, Yalin Tong, Jiansheng Li and Bingrong Liu in Life Sciences 237 (2019) 116893 https://doi.org/10.1016/j.lfs.2019.116893 and Figure 7F of the article published by Xiaoping Pan, Chen Wang, Yan Li, Lida Zhu and Ti Zhang in Life Sciences 214 (2018) 124-135 https://doi.org/10.1016/j.lfs.2018.10.064. Although this article was published earlier than the other articles, the Editor decided to retract this article given concerns about the reliability of the data.